Fearful Investors Should Buy Credit, Sell Stocks, JPMorgan Says

image

(Bloomberg) — Investors looking to protect themselves against more market turmoil should think about selling some blue chip companies’ shares and buying the corporations’ bonds instead, according to JPMorgan Chase & Co.

Such trades can generate more income for investors: yields on investment-grade corporate notes averaged 4.4% as of Monday’s close, according to Bloomberg index data, compared with the S&P 500 average dividend yield of about 1.5%. The current gap between the two yields, of about 2.9 percentage points, is the widest since 2009.

When debt yields were lower, some bond investors looked at buying equities with relatively high dividend yields, to earn income while also potentially generating gains from shares getting more valuable. Now it might make sense to consider the opposite trade: earning higher yields on bonds and getting the downside protection the debt securities can offer, JPMorgan strategists wrote in a note on Tuesday.

“By rotating an equity that has outperformed to a fixed-income security on the other side, you are locking in that yield until the maturity of the security,” Nathaniel Rosenbaum, JPMorgan U.S. high grade strategy analyst, said in a phone interview on Tuesday.

JPMorgan strategists said that the bank remains positive on both investment-grade risk premiums and equities now, but added that some investors are looking to protect their downside. The Federal Reserve started hiking rates in March for the first time since 2018 as it tries to get inflation under control. U.S. equities have lost 12.4% this year through Monday’s close after accounting for dividends.

JPMorgan listed a series of potential trades for investors to consider, screening for equities that had gained so far this year, a sign that they may have less upside if the market broadly rebounded. It also looked for companies with relatively high dividend yields, at least 3%, and whose bonds yielded even more. Among the companies it lists are Public Service Enterprise Group Inc. and Kellogg Co.

Elsewhere in credit markets:

Americas

Two companies are selling investment grade bonds on Tuesday, after multiple companies stood down Monday and were expected to try again. Volatility has thwarted many potential issuers from selling new bonds over the last couple of weeks as syndicate desks work to help clients navigate through tumultuous swings in asset prices.

  • Investors continue to flock to the U.S. leveraged loan market, viewing the floating-rate product favorably in light of imminent rate hikes and white-hot inflation. Leveraged loans are outperforming most other asset classes so far this year
  • A group of banks led by Wells Fargo & Co. is discussing with investors potential changes for a struggling junk bond deal for medical device manufacturer Bioventus Inc. in a bid to draw more demand
  • For deal updates, click here for the New Issue Monitor
  • For more, click here for the Credit Daybook Americas

EMEA

Four issuers sold the equivalent of 6.15 billion euros ($6.48 billion) of bonds.

  • Russia appears to be sidestepping a default, as its closely watched dollar payments on two bonds are trickling through to investors
  • The U.K. should sell sustainability-linked bonds to show its commitment to net zero and do more to secure Britain’s place as the global center of green finance, think-tank Social Market Foundation said in a report
  • The pace at which companies are postponing financing plans is slowing as some reinstate deals shelved since Russia’s invasion of Ukraine
  • Global sales of sustainability-linked loans continue to lag last year’s record issuance as corporates steer away from new financing plans amid global inflation and Russia’s war in Ukraine.

Asia

Little action is likely in Asia’s debt markets this week, with a public holiday in Tokyo through Thursday and China also out today. Tuesday is also a public holiday in India, where investors are digesting the biggest monthly jump in top-rated corporate bond yields in more than a year.

2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More